666 related articles for article (PubMed ID: 30677473)
1. Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.
Lauschke VM; Zhou Y; Ingelman-Sundberg M
Pharmacol Ther; 2019 May; 197():122-152. PubMed ID: 30677473
[TBL] [Abstract][Full Text] [Related]
2. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
Lauschke VM; Ingelman-Sundberg M
Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Lauschke VM; Milani L; Ingelman-Sundberg M
AAPS J; 2017 Nov; 20(1):4. PubMed ID: 29181807
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
Zhou Y; Lauschke VM
Expert Rev Clin Pharmacol; 2024 Mar; 17(3):213-223. PubMed ID: 38247431
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
[TBL] [Abstract][Full Text] [Related]
7. Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: A review.
Vaidhya A; Ghildiyal K; Rajawat D; Nayak SS; Parida S; Panigrahi M
Anim Genet; 2024 Feb; 55(1):3-19. PubMed ID: 37990577
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomic biomarkers for personalized medicine.
Chen JJ; Lin WJ; Chen HC
Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
[TBL] [Abstract][Full Text] [Related]
9. A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing.
Zhou Y; Koutsilieri S; Eliasson E; Lauschke VM
Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):452-464. PubMed ID: 35971800
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.
Zaza G; Granata S; Sallustio F; Grandaliano G; Schena FP
Clin Exp Immunol; 2010 Mar; 159(3):268-80. PubMed ID: 19968662
[TBL] [Abstract][Full Text] [Related]
11. Personalized medicine, pharmacogenomic and companion biomarker.
Manceau H; Amrani K; Peoc'h K
Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics and Personalized Medicine.
Cecchin E; Stocco G
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoepigenetics and Pharmacoepigenomics: An Overview.
Peedicayil J
Curr Drug Discov Technol; 2019; 16(4):392-399. PubMed ID: 29676232
[TBL] [Abstract][Full Text] [Related]
14. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
Zhou Y; Lauschke VM
Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
[TBL] [Abstract][Full Text] [Related]
15. The role of cost-effectiveness analysis in the era of pharmacogenomics.
Flowers CR; Veenstra D
Pharmacoeconomics; 2004; 22(8):481-93. PubMed ID: 15217305
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
Brandl E; Halford Z; Clark MD; Herndon C
Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
[TBL] [Abstract][Full Text] [Related]
17. Tools in Pharmacogenomics Biomarker Identification for Cancer Patients.
Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tagliaferri P; Arbitrio M
Methods Mol Biol; 2022; 2401():1-12. PubMed ID: 34902118
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
19. "
Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
[TBL] [Abstract][Full Text] [Related]
20. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
Mizzi C; Dalabira E; Kumuthini J; Dzimiri N; Balogh I; Başak N; Böhm R; Borg J; Borgiani P; Bozina N; Bruckmueller H; Burzynska B; Carracedo A; Cascorbi I; Deltas C; Dolzan V; Fenech A; Grech G; Kasiulevicius V; Kádaši Ľ; Kučinskas V; Khusnutdinova E; Loukas YL; Macek M; Makukh H; Mathijssen R; Mitropoulos K; Mitropoulou C; Novelli G; Papantoni I; Pavlovic S; Saglio G; Setric J; Stojiljkovic M; Stubbs AP; Squassina A; Torres M; Turnovec M; van Schaik RH; Voskarides K; Wakil SM; Werk A; Del Zompo M; Zukic B; Katsila T; Lee MT; Motsinger-Rief A; Mc Leod HL; van der Spek PJ; Patrinos GP
PLoS One; 2016; 11(9):e0162866. PubMed ID: 27636550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
